Theravance Biopharma
TBPH
TBPH
160 hedge funds and large institutions have $706M invested in Theravance Biopharma in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 47 increasing their positions, 41 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.19% more ownership
Funds ownership: 92.87% → 96.06% (+3.2%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
63% less call options, than puts
Call options by funds: $978K | Put options by funds: $2.66M
Holders
160
Holding in Top 10
4
Calls
$978K
Puts
$2.66M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$10.6M | |
| 3 | +$5.7M | |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$4.54M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.75M |
Top Sellers
| 1 | -$7.52M | |
| 2 | -$7.22M | |
| 3 | -$6.34M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$3.05M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.12M |
